Group 1 - The Sichuan Zhenxing Science and Technology Innovation Equity Investment Fund Partnership has completed its registration with a total scale of 5.055 billion yuan [1] - The fund is established with contributions from Sichuan Social Security Science and Technology Innovation Equity Investment Fund, Sichuan Juxin Zhiyuan Private Fund Management Co., Ltd., and CCB Investment Private Fund Management (Beijing) Co., Ltd. [1] - The fund will focus on investment areas including new energy, new materials, biomedicine, artificial intelligence, robotics, integrated circuits, and digital economy [1] Group 2 - The fund aims to create a virtuous cycle of technology-driven growth, industry acceleration, and stable value appreciation [1]

Core Insights - The article highlights significant developments in the investment landscape, particularly focusing on the establishment and funding of various investment funds across different regions in China, indicating a trend towards increased capital flow into innovative sectors. Group 1: Fund Establishments and Investments - Shenzhen's angel investment fund has relaxed return investment constraints, removing local registration requirements for fund managers, marking a pioneering move in the venture capital industry for 2026 [3] - Blue Pool Capital has successfully raised $1 billion (approximately 70 billion RMB), marking the largest dollar fundraising in China this year [4] - A new 100 billion RMB fund, the National Investment and Innovation Fund, has been established in Shanghai, backed by social security funds and major banks, signaling a strong commitment to supporting innovation [6] - The Shanghai Integrated Circuit Industry Private Equity Fund has been launched with an initial scale of 57.02 million RMB, representing a significant step in the city's merger and acquisition strategy [7] - Singapore's Fenglong Xinghe Private Limited has injected 500 million RMB into Shanghai's technology innovation center, focusing on key industries such as integrated circuits and artificial intelligence [9] - Two low-altitude industry funds in Shenzhen have been established, totaling over 1.3 billion RMB, aimed at boosting the low-altitude economy [10] - Chengdu has set up a talent fund with a target scale of 1 billion RMB, focusing on supporting technology talent and quality projects [11] - The Zhongguancun Science City Technology Growth Fund and the Achievement Transformation Fund have completed registration, with a total scale of 10 billion RMB, aimed at supporting strategic emerging industries [12] - The Guangdong Intelligent Robot Fund has been registered with a total scale of 10 billion RMB, focusing on AI and advanced manufacturing [14] - The Shanghai Pudong Smart Manufacturing Phase II Fund has been established with a target scale of 1 billion RMB, focusing on enhancing the local industrial chain [15] - The Shanghai Jiao Yin Guo Xin Fund has been set up with an initial scale of 1 billion RMB, aimed at supporting Shanghai's technology innovation center [16] - The Hubei New Chu Seed Fund has completed registration with a total scale of 500 million RMB, focusing on seed investments in technology projects [19] Group 2: Policy Developments and Strategic Initiatives - Guangdong Province has introduced a new policy to support artificial intelligence OPC innovation development, marking a significant step in promoting new entrepreneurial models [40] - The Beijing-Tianjin-Hebei Venture Capital Guidance Fund has completed its first batch of key project agreements, with a total scale of 1 billion RMB, focusing on early-stage investments in strategic emerging industries [25] - The Hainan Free Trade Port Construction Investment Fund is set to invest in two GP funds, with a total scale of 1.2 billion RMB for one fund and 400 million RMB for another, aimed at supporting innovation in the region [27]

Group 1 - The National Social Security Fund (NSSF) is collaborating with various local governments to establish innovation-driven funds, with a total scale of 100 billion yuan for the Guotou Science and Technology Innovation Fund in Shanghai [2] - The Zhejiang Social Security Innovation Fund has been established with an initial scale of 50 billion yuan, focusing on key industries such as artificial intelligence and biomedicine [3] - The Fujian (Xiamen) Social Security Innovation Fund has been launched with an initial scale of 20 billion yuan, managed by Xiamen Chuangtou [3] - The Jiangsu Social Security Innovation Fund has been approved with a scale of 50 billion yuan, adopting a dual-layer management structure [3] - The Hubei Social Security Innovation Fund has been established with a scale of 20 billion yuan, targeting industries like optoelectronics and automotive manufacturing [4] - The Sichuan Social Security Innovation Fund has been signed with an initial scale of 20 billion yuan, focusing on strategic emerging industries [4] Group 2 - The entry of social security funds is expected to attract more private capital towards national strategic industries, providing stable funding support for technology enterprises with long innovation cycles [5]

Core Viewpoint - The article highlights the increasing focus on scientific instruments in national policies and the accelerated capital investment in high-tech sectors, particularly through the establishment of various mother funds across multiple regions in China [3]. Group 1: Fund Establishments and Focus Areas - Beijing's Huairou District has launched a guiding fund with a total scale of 5 billion yuan, focusing on scientific instruments, sensors, new materials, and other high-tech fields to support technological innovation and high-quality industrial development [4]. - In Taizhou, Zhejiang, the newly established Chuangxin Mother Fund has a total scale of 2 billion yuan, targeting strategic emerging industries such as automotive parts, semiconductors, and intelligent manufacturing [5]. - Hubei Province has set up a cultural tourism investment fund with a total scale of 10 billion yuan, with part of the investment directed towards artificial intelligence, life health, and advanced manufacturing sectors [6]. - Rugao City in Jiangsu has initiated a mother fund with a total scale of 1 billion yuan, focusing on precision optics, synthetic biology, and high-end equipment [8]. - The Xuyi Advanced Industry Investment Fund in Jiangsu has been established with a total scale of 2 billion yuan, concentrating on advanced manufacturing and artificial intelligence [9]. - Yancheng's specialized and innovative industry fund has a total scale of 500 million yuan, aimed at supporting high-tech enterprises with core technologies [10]. - Guangxi has launched a technology achievement transformation mother fund with a total scale of 2 billion yuan, focusing on artificial intelligence and high-end equipment manufacturing [11]. - The Guilin Science and Technology Innovation Equity Investment Fund has been approved with a scale of 500 million yuan, supporting sectors like artificial intelligence and advanced equipment manufacturing [12]. - Dongguan has registered a 100 million yuan fund targeting emerging industries including new generation information technology and high-end equipment manufacturing [13]. - Wuhan's venture capital fund has been established with a scale of 100 million yuan, focusing on new generation information technology and high-end equipment [14].

Group 1 - The article highlights the establishment and funding of various mother funds across multiple regions in China, focusing on sectors such as artificial intelligence, biomedicine, high-end manufacturing, new energy, and new materials [2][3][4] - Beijing's Huairou District has launched a government investment guidance fund with a total scale of 5 billion yuan, which does not have a set duration and aims to support various innovative industries [4] - Jiangsu, Hubei, and Fujian have also announced the establishment of funds targeting similar high-tech sectors, with specific funds like the 2 billion yuan advanced industry fund in Xuyi focusing on intelligent manufacturing [3][5] Group 2 - Hubei's cultural tourism investment fund has a total scale of 10 billion yuan, with an initial phase of 2 billion yuan, focusing on cultural and tourism sectors, as well as strategic emerging industries like artificial intelligence and biomedicine [6][7] - The fund aims to create a comprehensive investment system through a mother-child fund structure, targeting various modern service industries [6][7] - The fund is open for GP selection, emphasizing investment in cultural tourism, health, advanced manufacturing, and digital intelligence sectors [7] Group 3 - The establishment of the 10 billion yuan Longjiang New Area Future Industry Guidance Fund in Wuhan aims to invest in future industries such as new energy and artificial intelligence [22][23] - The fund will utilize a market-oriented selection mechanism to ensure investment in high-potential projects [23] - The 30 billion yuan Yixing Artificial Intelligence Industry Fund focuses on integrating AI with local manufacturing and aims to support the digital transformation of industries [24] Group 4 - The 20 billion yuan Guangxi Technology Achievement Transformation Mother Fund is designed to support cutting-edge technologies and future industries, with a focus on original innovation [10][11] - The fund will allocate at least 80% of its resources to establish sub-funds, targeting strategic emerging industries [10][11] - The 30 billion yuan Yangquan High-tech Industry Development Zone Fund aims to invest in new energy and strategic emerging industries, with a focus on local industrial needs [12][13] Group 5 - The Jiangsu Yancheng Green Low-Carbon Industry Special Mother Fund has a total scale of 2 billion yuan, focusing on green and low-carbon industries [15] - The fund aims to support the development of strategic emerging industry clusters and optimize the local industrial layout [15] - The 5 billion yuan Fuzhou Low Altitude Industry Fund will focus on the low-altitude economy, linking regional resources with industry needs [27] Group 6 - The establishment of the 5 billion yuan Guilin Science and Technology Innovation Fund aims to support industries such as artificial intelligence and biomedicine [29] - The fund has already identified 61 projects with a total financing demand of approximately 2.686 billion yuan [29] - The 10 billion yuan Zhongliang Haihe New Emerging Industry Investment Fund will focus on private equity investments and asset management [30]

Market Overview - On March 18, the three major indices closed higher, with the Shanghai Composite Index ending a four-day losing streak, rising by 0.32%[3] - The Shenzhen Component Index increased by 1.05%, and the ChiNext Index rose by 2.02%[3] Trading Volume and Market Sentiment - On March 19, the trading volume was 2.06 trillion yuan, a decrease of approximately 160 billion yuan from the previous trading day[1] - The market showed signs of weakness in the morning but rebounded in the afternoon, although the volume was insufficient to support the rally[1] Sector Performance - Over half of the sectors saw gains, with telecommunications, computers, electronics, and military industries leading the increases[1] - Conversely, sectors such as oil, real estate, and food and beverage experienced declines[1] Capital Flow - On March 18, net inflows into the Shanghai Stock Exchange were 16.059 billion yuan, while the Shenzhen Stock Exchange saw net inflows of 28.337 billion yuan[4] - The top three sectors for capital inflow were telecommunications equipment, semiconductors, and IT services, while the top outflow sectors included batteries, securities, and passenger vehicles[4] Policy and Investment - The National Development and Reform Commission announced a new batch of 13 major foreign investment projects with a planned investment of 13.4 billion USD, focusing on manufacturing sectors like electronics and chemicals[5] - The Ministry of Industry and Information Technology emphasized promoting advanced technology applications to enhance the comprehensive utilization of waste tires[6] Fundraising Trends - In March, nearly 40 actively managed equity funds raised over 1 billion yuan each, with 7 funds established on March 18 alone, 5 of which exceeded this threshold[16]

Key Points - The article discusses significant events in the private equity fund market from March 9 to March 15, 2026, highlighting various funds established and their investment focuses [5]. Government-Backed Funds - The Beijing-Tianjin-Hebei Venture Capital Guidance Fund has completed its registration with a total scale of 50 billion yuan, focusing on early-stage investments in hard technology [7]. - The Chaoyang Science and Technology Innovation Fund is seeking GP for a sub-fund that will invest in the exhibition industry, emphasizing AI and big data applications [8]. - Guizhou Province has launched its first aviation industry guidance fund with an initial scale of 400 million yuan, targeting key enterprises in the aerospace sector [9]. - The Xuzhou Economic Development Zone has established a specialized industrial fund with a total scale of 1.5 billion yuan, focusing on smart manufacturing and digital economy [9]. - The Yancheng Economic and Technological Development Zone is selecting GP for a 1 billion yuan mother fund aimed at supporting advanced manufacturing [9]. Market-Driven Funds - The Huizhou Technology Innovation Fund has been established with a total scale of 500 million yuan, focusing on AI and life sciences [16]. - The Shanghai Pudong Intelligent Manufacturing Phase II Fund has been set up with an initial scale of 325 million yuan, targeting hard technology projects [17]. - Zijin Mining has established a 280 million yuan dual circulation fund focusing on logistics supply chain and new energy [17]. - Zhejiang Medicine has committed 157 million yuan to a private equity fund focusing on the biopharmaceutical sector [18]. - The Guangxi Wuzhou Zhongheng Group has announced a 150 million yuan investment in a venture capital fund targeting innovative biomedicine and medical devices [19]. Industry-Specific Funds - The Sichuan Oil and Gas Equity Investment Guidance Fund has been registered with a scale of 1 billion yuan, focusing on oil and gas exploration rights [14]. - The Wuxi Weiwang Innovative Drug Accelerator Fund has been signed with a total scale of 2 billion yuan, aimed at supporting innovative drug enterprises [11]. - The Yibin City has launched a 2 billion yuan AI industry development fund, focusing on AI applications and infrastructure [12]. - The Hangzhou Gongshu District Talent Intelligent Entrepreneurship Fund has been established with a scale of 80 million yuan, focusing on AI and life sciences [16]. - The Jiangsu Province has set up a 1.7 billion yuan fund targeting advanced manufacturing and core technologies [22].

Investment Rating - The report assigns a "Buy" rating for King’s Ray Biotechnology (1548.HK) based on its strong performance and growth potential in the biopharmaceutical market [1]. Core Insights - King’s Ray Biotechnology reported a robust revenue of $960 million for 2025, marking a year-on-year growth of 61.4%. The adjusted net profit reached $230 million, reflecting a significant increase of 285% [1][2]. - The company operates three main business segments: Life Sciences, Prosperous Biotech, and BestJet, all showing positive growth trends [2]. Summary by Business Segment Life Sciences - In 2025, the Life Sciences segment generated $522 million in revenue, a 14.8% increase year-on-year. The adjusted gross profit was $267 million, with a gross margin of 51% [3]. - The European market showed significant growth, with revenue share increasing from 16% in 2024 to 19% in 2025. The segment is expected to maintain its leading position in the industry [3]. Prosperous Biotech - Prosperous Biotech achieved $389 million in revenue, a remarkable growth of 309.1%. Excluding milestone revenues, the organic growth was 21% [4]. - The segment added 41 new CDMO projects, a 46% increase, and completed multiple GMP batches for multinational pharmaceutical companies [4]. BestJet - BestJet reported $58 million in revenue, a 7.9% increase year-on-year, with an adjusted gross profit of $23 million [5]. - The segment is focusing on strategic R&D investments, with a 140% increase in R&D efficiency due to AI integration [5]. 2026 Performance Guidance - The company provided strong performance guidance for 2026, with expected revenue growth of 15-18% for the Life Sciences segment and 20-25% for Prosperous Biotech [5]. - BestJet aims for a revenue increase of 10-15% in 2026, indicating a comprehensive acceleration in growth confidence compared to 2025 [5].

1. Report Industry Investment Rating - No relevant information provided 2. Core Views of the Report - Last week, the A-share market showed resilience in the game between external geopolitical shocks and internal policy support, presenting a volatile and differentiated pattern. The ChiNext Index led the rise by 2.5%, while the Shanghai Composite Index slightly declined by 0.7%, with significant market structural characteristics. The core driving factors of the market include external factors such as the repeated situation in the Middle East, which suppresses risk appetite and causes large fluctuations in stock indices in countries like Japan and South Korea. The continuous conflict has led to the international oil price exceeding $100 per barrel, and the market's re - inflation concerns suppress the prospects of monetary policy interest rate cuts. Internally, in the first year of the "15th Five - Year Plan", policies focus on new - quality productivity, and technology - growth sectors such as AI computing power, semiconductors, and biomedicine are supported by both policies and industrial trends. The inflation in February moderately rebounded, and exports in the first two months greatly exceeded expectations, strengthening the narrative of global re - industrialization and the dominance of resources. Overall, the market rapidly rotates between defensive and growth sectors [1]. - In the later stage, the conflict between the US and Iran may continue to be the most important marginal variable in March. Currently, the passage of the Strait of Hormuz will continue to be blocked, leading to high oil prices. If inflation expectations continue to lead to stagflation expectations, the market still needs to consolidate. The results of the Fed's interest - rate meeting this week should be focused on. It is expected that the market will continue the volatile consolidation pattern, and the structural characteristics may continue. On the one hand, the cyclical resource sectors may continue to benefit from the strong oil price pattern. On the other hand, the demand for resources from AI development and its substitution effect on some industries resonate, and the market prefers the HALO trading strategy of heavy - asset and low - elimination. Due to the domestic policy remaining in a loose tone, the expectation of market stability still exists, laying the foundation for the "slow - bull" pattern of the A - share market [2]. 3. Summary by Relevant Catalogs 3.1 Market Review and Outlook - **Stock Market Performance**: Last week, most global stock indices fell. In the US, the Dow Jones Industrial Average fell 1.99%, the S&P 500 fell 1.6%, and the Nasdaq fell 1.26%. In Europe, the UK's FTSE 100 fell 0.23%, Germany's DAX fell 0.61%, and France's CAC 40 fell 1.03%. In the Asia - Pacific market, Japan's Nikkei 225 fell 3.24%, and the Hang Seng Index fell 1.13%. The Shanghai Composite Index fell 0.7%, while the ChiNext Index rose 2.5% [1][10]. - **Sector Performance**: Coal, power equipment, and building decoration sectors led the gains, while national defense and military industry, petroleum and petrochemical, and comprehensive sectors led the losses [1]. - **Driving Factors**: Externally, the repeated Middle East situation suppresses risk appetite, and the high oil price due to the conflict leads to re - inflation concerns and suppresses the prospects of interest rate cuts. Internally, policies focus on new - quality productivity, and economic data such as inflation and exports support the narrative of global re - industrialization and resource dominance [1]. 3.2 Strategy Recommendations - **Short - term Strategy**: The intraday trading frequency can refer to the 1 - minute and 5 - minute K - line charts. The stop - loss and take - profit levels for IF, IH, IC, and IM can be set at 93 points/70 points, 74 points/44 points, 205 points/246 points, and 246 points/205 points respectively [4]. - **Trend Strategy**: Adopt the idea of buying on dips or trading within a range. The core operating range of the IF2603 main contract is between 4542 and 4751 points; the IH2603 main contract is between 2883 and 3016 points; the IC2603 main contract is between 7885 and 8501 points; the IM2603 main contract is between 7900 and 8514 points [4]. - **Cross - variety Strategy**: It is expected that the switch between value and growth will be relatively frequent [5]. 3.3 Spot Market Review - **Global Stock Index Performance**: Most global stock indices fell last week. The US, European, and Asia - Pacific stock markets all showed different degrees of decline, with only the Russian RTS remaining unchanged [10]. - **A - share Index Performance**: The ChiNext Index led the rise, while the Shanghai Composite Index slightly declined. Different A - share indices showed different trends [12]. - **Industry Performance in A - share Indices**: In the CSI 300 and CSI 500 indices, different industries showed mixed rises and falls [13]. 3.4 Stock Index Futures Market Review - **Futures Contract Performance**: The IC main contract had the largest decline and the largest amplitude last week. The trading volume and open interest of stock index futures both increased [17]. - **Basis and Cross - variety Ratio**: The basis (futures - spot) of stock index futures main contracts and the cross - variety ratio showed certain trends [17][18]. 3.5 Index Valuation Tracking - As of March 6, the price - to - earnings ratio (TTM) of the Shanghai Composite Index was 17.19 times, the CSI 300 Index was 14.23 times, the SSE 50 Index was 11.59 times, the CSI 500 Index was 38.02 times, and the CSI 1000 Index was 50.88 times [18][21]. 3.6 Market Capital Flow Review - **Margin Trading Balance**: The margin trading balance in the two markets and the proportion of margin trading balance to the A - share floating market value showed certain trends [21]. - **Newly Established Equity - Oriented Funds**: The share of newly established equity - oriented funds showed a certain change [21]. - **Funding Rate and Central Bank Operations**: The funding rate once declined last week, and the central bank had a net withdrawal of funds [22].

Investment Rating - The report assigns a "Buy" rating to the pharmaceutical industry, indicating a positive outlook for the next 6-12 months [5][60]. Core Insights - The "14th Five-Year Plan" positions biomedicine as a strategic emerging industry, creating unprecedented opportunities for the pharmaceutical sector. The plan emphasizes a comprehensive support system for the entire chain from research and development to payment and usage, which is expected to accelerate the approval and market entry of innovative drugs [4][59]. - The integration of AI with biomedicine is transitioning from concept to industrialization, promising a revolution in drug discovery and development efficiency [5][60]. Summary by Sections Market Review - The A-share biotechnology sector declined by 1.26%, while the chemical preparation sector fell by 0.82%. The Hang Seng Healthcare index dropped by 3.11%, ranking as the 10th largest decline among major sectors [1][9]. Industry Dynamics and Important Announcements - The recent government announcement highlights the inclusion of biomedicine in the strategic emerging industries, with a focus on optimizing the approval process for innovative drugs and reforming medical insurance payment methods to enhance accessibility [3][58]. Investment Recommendations - The report emphasizes that companies capable of commercializing leading products overseas and demonstrating continuous innovation will be favored in the market. The focus is on the quality of licensing agreements and the robustness of clinical data [5][60].